{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:31:39Z","timestamp":1793568699095,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["54,265,341"],"award-info":[{"award-number":["54,265,341"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.breast.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T12:01:10Z","timestamp":1680091270000},"page":"349-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Patients\u2019 experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study"],"prefix":"10.1016","volume":"69","author":[{"given":"K.","family":"Bokkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.A.","family":"Bleiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Velthuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Koelemij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.J.","family":"Burgmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Klinkenbijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Schouten van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Vermulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.F.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Witkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Frakking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Brohet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Aalfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.P.","family":"Schoenmaeckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-3477","authenticated-orcid":false,"given":"M.G.E.M.","family":"Ausems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 5","key":"10.1016\/j.breast.2023.03.017_bib1","doi-asserted-by":"crossref","first-page":"v103","DOI":"10.1093\/annonc\/mdw327","article-title":"Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening","volume":"27","author":"Paluch-Shimon","year":"2016","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.breast.2023.03.017_bib2","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.20.00299","article-title":"Management of hereditary breast cancer: American society of clinical oncology, American society for radiation oncology, and society of surgical oncology guideline","volume":"38","author":"Tung","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2023.03.017_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41416-018-0127-5","article-title":"BRCA1\/2 testing: therapeutic implications for breast cancer management","volume":"119","author":"Tung","year":"2018","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2023.03.017_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","article-title":"Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Gradishar","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"issue":"25","key":"10.1016\/j.breast.2023.03.017_bib5","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.breast.2023.03.017_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.annonc.2022.09.159","article-title":"Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer","volume":"33","author":"Geyer","year":"2022","journal-title":"Ann Oncol"},{"issue":"34","key":"10.1016\/j.breast.2023.03.017_bib7","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","article-title":"National estimates of genetic testing in women with a history of breast or ovarian cancer","volume":"35","author":"Childers","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2023.03.017_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10897-017-0158-8","article-title":"Projecting the supply and demand for certified genetic counselors: a workforce study","volume":"27","author":"Hoskovec","year":"2018","journal-title":"J Genet Counsel"},{"issue":"1","key":"10.1016\/j.breast.2023.03.017_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.c.31602","article-title":"The past, present and future of service delivery in genetic counseling: keeping up in the era of precision medicine","volume":"178","author":"Stoll","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"13","key":"10.1016\/j.breast.2023.03.017_bib10","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1200\/JCO.2017.76.2781","article-title":"Evaluation of a streamlined oncologist-led BRCA mutation testing and counseling model for patients with ovarian cancer","volume":"36","author":"Colombo","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.03.017_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep29506","article-title":"Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients","volume":"6","author":"George","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.breast.2023.03.017_bib12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/cancers14041059","article-title":"The feasibility of implementing mainstream germline genetic testing in routine cancer care-A systematic review","volume":"14","author":"Bokkers","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.breast.2023.03.017_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ajco.13334","article-title":"Mainstream consent programs for genetic counseling in cancer patients: a systematic review","volume":"17","author":"Scheinberg","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2023.03.017_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41431-021-00848-3","article-title":"Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre","volume":"29","author":"Beard","year":"2021","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.breast.2023.03.017_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10689-020-00160-x","article-title":"Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway","volume":"19","author":"Grindedal","year":"2020","journal-title":"Fam Cancer"},{"issue":"5","key":"10.1016\/j.breast.2023.03.017_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4428","article-title":"Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer","volume":"2","author":"Kemp","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.breast.2023.03.017_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/cancers12020338","article-title":"Oncology clinic-based hereditary cancer genetic testing in a population-based health care system","volume":"12","author":"Richardson","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.breast.2023.03.017_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13053-022-00212-6","article-title":"It was an important part of my treatment\": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing","volume":"20","author":"Stromsvik","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"issue":"12","key":"10.1016\/j.breast.2023.03.017_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2020.104098","article-title":"Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic","volume":"63","author":"Benusiglio","year":"2020","journal-title":"Eur J Med Genet"},{"issue":"12","key":"10.1016\/j.breast.2023.03.017_bib20","first-page":"1873","article-title":"Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low-to-middle income Asian country","volume":"25","author":"Lee","year":"2022","journal-title":"J Genet Counsel"},{"issue":"2","key":"10.1016\/j.breast.2023.03.017_bib21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/curroncol28020138","article-title":"A comparison of patient-reported outcomes following consent for genetic testing using an oncologist- or genetic counselor-mediated model of care","volume":"28","author":"McCuaig","year":"2021","journal-title":"Curr Oncol"},{"issue":"10","key":"10.1016\/j.breast.2023.03.017_bib22","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.12968\/bjon.2020.29.10.S6","article-title":"Changing practice: moving to a specialist nurse-led service for BRCA gene testing","volume":"29","author":"Scott","year":"2020","journal-title":"Br J Nurs"},{"issue":"6","key":"10.1016\/j.breast.2023.03.017_bib23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10897-018-0261-5","article-title":"Patients' views of treatment-focused genetic testing (TFGT): some lessons for the mainstreaming of BRCA1 and BRCA2 testing","volume":"27","author":"Wright","year":"2018","journal-title":"J Genet Counsel"},{"issue":"2","key":"10.1016\/j.breast.2023.03.017_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10689-022-00313-0","article-title":"A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and\/or ovarian cancer in three tertiary Cancer Centres in Ireland","volume":"22","author":"McVeigh","year":"2023","journal-title":"Fam Cancer"},{"key":"10.1016\/j.breast.2023.03.017_bib25","article-title":"Surgical oncologists and nurses in breast cancer care are ready to provide pre-test genetic counseling","author":"Bokkers","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2023.03.017_bib26","series-title":"Breast cancer guideline","year":"2020"},{"issue":"1","key":"10.1016\/j.breast.2023.03.017_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13053-022-00238-w","article-title":"Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing","volume":"20","author":"Bokkers","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"issue":"2","key":"10.1016\/j.breast.2023.03.017_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/ijgc-2019-000630","article-title":"Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process","volume":"30","author":"McLeavy","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.breast.2023.03.017_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/jso.24763","article-title":"Rapid genetic counseling and testing in newly diagnosed breast cancer: patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making","volume":"116","author":"Wevers","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.breast.2023.03.017_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103797","article-title":"Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: legal and ethical challenges","volume":"178","author":"Charron","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.breast.2023.03.017_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623004344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623004344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:47:59Z","timestamp":1760777279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977623004344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"alternative-id":["S0960977623004344"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2023.03.017","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients\u2019 experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}